Recent advances and applications of peptide–agent conjugates for targeting tumor cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent advances and applications of peptide–agent conjugates for targeting tumor cells

Published:2023-08-15 Issue:16 Volume:149 Page:15249-15273
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Alamdari-palangi Vahab,Jaberi Khojaste Rahimi,Shahverdi Mahshid,Naeimzadeh Yasaman,Tajbakhsh Amir,Khajeh Sahar,Razban Vahid,Fallahi Jafar

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-05144-9.pdf

Reference262 articles.

1. Abdelmageed MI, Abdelmoneim AH, Mustafa MI, Elfadol NM, Murshed NS, Shantier SW, Makhawi AM (2020) Design of a multiepitope-based peptide vaccine against the E protein of human COVID-19: an immunoinformatics approach. BioMed Res Int 2020:1–12

2. Ackler S, Mitten MJ, Foster K, Oleksijew A, Refici M, Tahir SK, Xiao Y, Tse C, Frost DJ et al (2010) The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo. Cancer Chemother Pharmacol 66:869–880. https://doi.org/10.1007/s00280-009-1232-1

3. Adebomi V, Cohen RD, Wills R, Chavers HAH, Martin GE, Raj M (2019) CyClick chemistry for the synthesis of cyclic peptides. Angew Chem 131:19249–19256

4. Adis R&D Profile (2005) Histrelin hydrogel implant–valera: Histrelin implant, LHRH-Hydrogel implant, RL 0903, SPD 424. Drugs R D 6:53–55. https://doi.org/10.2165/00126839-200506010-00007

5. Adotévi O, Vernerey D, Jacoulet P, Meurisse A, Laheurte C, Almotlak H, Jacquin M, Kaulek V, Boullerot L et al (2023) Safety, immunogenicity, and 1-year efficacy of universal cancer peptide-based vaccine in patients with refractory advanced non-small-cell lung cancer: a phase Ib/phase IIa de-escalation study. J Clin Oncol 41:373–384. https://doi.org/10.1200/jco.22.00096

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and synthesis of TH19P01-Camptothecin based hybrid peptides inducing effective anticancer responses on sortilin positive cancer cells;Bioorganic & Medicinal Chemistry;2024-09

2. Biosurfactant Nanomicelles and Peptide Integration: Novel Approaches to Targeted Gene Delivery in Colon Cancer Treatment;Current Medicinal Chemistry;2024-08-22

3. Screening and Exploring the Application of the Multifunctional Antioxidant Peptides MSWLC and TSWLC;Advanced Healthcare Materials;2024-08-05

4. Biological Activity of Natural and Synthetic Peptides as Anticancer Agents;International Journal of Molecular Sciences;2024-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3